Over the last two decades, Sam has led or invested in a number of businesses within life sciences.
Most recently as CEO of Cenduit an eClinical technology firm from 2016 to 2020 (successful sale to IQVIA in December 2019). Previously with Quintiles, the largest Contract Research Organization where he oversaw a number of businesses focused on patient centricity, data collection, safety monitoring. He also held business development roles spanning across clinical and commercial phases.
Earlier career in venture capital followed by investment banking with Citigroup focused on consumer and healthcare verticals.
BSc, Economics, Biochemistry, University of Tampa; MSc Economics, London School of Economics; MBA with distinction Carnegie Mellon University; Advanced Management, University of Pennsylvania.